(Q24685403)

2

0 references

B I Korelitz

3

0 references

C Brensinger

4

0 references

J D Lewis

Long-term risk of malignancy after treatment of inflammatory bowel disease with azathioprine

5

0 references

language of work or name

English

0 references

publication date

August 2005

0 references

published in

Gut

0 references

volume

54

0 references

issue

8

0 references

page(s)

1121-5

0 references

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1774897

Risk of lymphoma in inflammatory bowel disease

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1774897

Increased incidence of non-Hodgkin's lymphoma in inflammatory bowel disease patients on immunosuppressive therapy but overall risk is low

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1774897

Azathioprine: state of the art in inflammatory bowel disease

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1774897

Lymphoproliferative cancer and other malignancy in patients with rheumatoid arthritis treated with azathioprine: a 20 year follow up study

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1774897

Malignant neoplasms subsequent to treatment of inflammatory bowel disease with 6-mercaptopurine

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1774897

Increased risk of cancer in ulcerative colitis: a population-based cohort study

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1774897

Incidence of cancer in rheumatoid arthritis and other disorders after immunosuppressive treatment

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1774897

Extracolonic malignancies in inflammatory bowel disease

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1774897

Hodgkin's disease risk is increased in patients with ulcerative colitis.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1774897

Cancer risk in patients with inflammatory bowel disease: a population-based study

28 November 2018

1 reference

12 December 2020

Inflammatory bowel disease is not associated with an increased risk of lymphoma

1 reference

12 December 2020

Increased frequency of posttransplant lymphomas in patients treated with cyclosporine, azathioprine, and prednisone

1 reference

12 December 2020

Incidence of non-Hodgkin lymphoma in kidney and heart transplant recipients

1 reference

12 December 2020

Long-term neoplasia risk after azathioprine treatment in inflammatory bowel disease

1 reference

12 December 2020

Crohn's disease and cancer: a population-based cohort study

1 reference

12 December 2020

Risk of developing certain malignancies is related to duration of immunosuppressive drug exposure in patients with rheumatic diseases

1 reference

12 December 2020

Azathioprine for maintenance of remission in Crohn's disease: benefits outweigh the risk of lymphoma

1 reference

12 December 2020

Identifiers

DOI

10.1136/GUT.2004.049460

1 reference

1 reference

1 reference

PubMed publication ID

16009685

1 reference